Compass Therapeutics (CMPX) Current Leases (2023 - 2025)
Historic Current Leases for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $633000.0.
- Compass Therapeutics' Current Leases rose 1364.45% to $633000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $633000.0, marking a year-over-year increase of 1364.45%. This contributed to the annual value of $338000.0 for FY2024, which is 7176.27% down from last year.
- According to the latest figures from Q3 2025, Compass Therapeutics' Current Leases is $633000.0, which was up 1364.45% from $271000.0 recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Current Leases ranged from a high of $1.2 million in Q1 2024 and a low of $109000.0 during Q1 2025
- Moreover, its 3-year median value for Current Leases was $1.1 million (2024), whereas its average is $805454.5.
- The largest annual percentage gain for Compass Therapeutics' Current Leases in the last 5 years was 1364.45% (2025), contrasted with its biggest fall of 9109.48% (2025).
- Quarter analysis of 3 years shows Compass Therapeutics' Current Leases stood at $1.2 million in 2023, then crashed by 71.76% to $338000.0 in 2024, then skyrocketed by 87.28% to $633000.0 in 2025.
- Its last three reported values are $633000.0 in Q3 2025, $271000.0 for Q2 2025, and $109000.0 during Q1 2025.